http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01100174-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-10
filingDate 1988-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_693c4b51dfbcd3baa54d5e136a7407fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc117bef685588ee5c7ffd6374bd180c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21c93c0017af14b2695f6f340c5aa02b
publicationDate 1989-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H01100174-A
titleOfInvention Substituted aromatic sulfonamide as antiglaucoma agent
abstract Aromatic sulfonamides with a saturated heterocycle fused thereto are carbonic anhydrase inhibitors useful in the treatment of elevated intraocular pressure.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009534349-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004508375-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015521649-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10324640-A
priorityDate 1987-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229333833

Total number of triples: 38.